Oxaflozane: Difference between revisions

From WikiMD's Wellness Encyclopedia

CSV import
Tags: mobile edit mobile web edit
 
CSV import
 
Line 1: Line 1:
'''Oxaflozane''' (INN) is a [[chemical compound]] and [[antidepressant]] that was introduced in France by [[Lafon Laboratories]] in 1982 for the treatment of [[depression]]. It is a [[serotonin antagonist and reuptake inhibitor]] (SARI) and acts as a [[receptor antagonist]] at several [[serotonin receptor]]s and as a [[serotonin reuptake inhibitor]].
{{Short description|Overview of the antidepressant drug Oxaflozane}}
{{Drugbox
| verifiedrevid = 123456789
| image = Oxaflozane.svg
| image_size = 200px
| image_alt = Structural formula of Oxaflozane
}}


==Chemistry==
'''Oxaflozane''' is a pharmaceutical drug that belongs to the class of [[antidepressants]]. It is primarily used in the treatment of [[depression]] and [[anxiety disorders]].
Oxaflozane is a [[tricyclic compound]], specifically a dibenzoxazepine, and possesses three rings fused together with a side chain attached at one of the ring junctions. It is a member of the diphenylbutylpiperidine class of antipsychotics.


==Pharmacology==
==Pharmacology==
Oxaflozane is a potent and selective antagonist of the [[5-HT2A receptor]], and this action is thought to be involved in its antidepressant effects. It also has weak inhibitory effects on the reuptake of [[serotonin]].
Oxaflozane functions as a [[serotonin]] reuptake inhibitor and a [[serotonin receptor]] agonist. This dual mechanism of action contributes to its efficacy in alleviating symptoms of depression and anxiety. By inhibiting the reuptake of serotonin, Oxaflozane increases the availability of this neurotransmitter in the [[synaptic cleft]], enhancing mood and emotional stability.
 
==Mechanism of Action==
[[File:Oxaflozane.svg|thumb|right|200px|Chemical structure of Oxaflozane]]
The mechanism of action of Oxaflozane involves modulation of the [[serotonergic system]]. It binds to serotonin receptors, particularly the [[5-HT1A receptor]], acting as a partial agonist. This action helps in normalizing the serotonergic activity in the brain, which is often disrupted in patients with depression and anxiety disorders.


==Clinical Use==
==Clinical Use==
Oxaflozane was used in France for the treatment of depression until it was discontinued in 2002 due to poor sales. It was never approved for use in the United States or any other country.
Oxaflozane is prescribed for patients diagnosed with major depressive disorder and generalized anxiety disorder. It is considered effective in cases where patients do not respond adequately to other antidepressants. The drug is administered orally, and the dosage is adjusted based on the patient's response and tolerance.


==Side Effects==
==Side Effects==
Common side effects of oxaflozane include [[dizziness]], [[dry mouth]], [[insomnia]], and [[nausea]]. Rare side effects include [[agitation]], [[anxiety]], and [[hallucinations]].
Common side effects of Oxaflozane include [[nausea]], [[dizziness]], and [[insomnia]]. Some patients may experience [[dry mouth]], [[constipation]], or [[sexual dysfunction]]. It is important for patients to report any severe or persistent side effects to their healthcare provider.
 
==Contraindications==
Oxaflozane is contraindicated in patients with a known hypersensitivity to the drug or its components. It should be used with caution in patients with a history of [[bipolar disorder]], as it may induce [[mania]].


==See Also==
==Related pages==
* [[List of antidepressants]]
* [[Antidepressant]]
* [[List of serotonin antagonists]]
* [[Serotonin]]
* [[Anxiety disorder]]
* [[Major depressive disorder]]


[[Category:Antidepressants]]
[[Category:Antidepressants]]
[[Category:Serotonin antagonists]]
[[Category:Serotonin reuptake inhibitors]]
[[Category:Serotonin reuptake inhibitors]]
[[Category:Tricyclic antidepressants]]
{{Antidepressant-stub}}

Latest revision as of 03:33, 13 February 2025

Overview of the antidepressant drug Oxaflozane


Oxaflozane
INN
Drug class
Routes of administration
Pregnancy category
Bioavailability
Metabolism
Elimination half-life
Excretion
Legal status
CAS Number
PubChem
DrugBank
ChemSpider
KEGG


Oxaflozane is a pharmaceutical drug that belongs to the class of antidepressants. It is primarily used in the treatment of depression and anxiety disorders.

Pharmacology[edit]

Oxaflozane functions as a serotonin reuptake inhibitor and a serotonin receptor agonist. This dual mechanism of action contributes to its efficacy in alleviating symptoms of depression and anxiety. By inhibiting the reuptake of serotonin, Oxaflozane increases the availability of this neurotransmitter in the synaptic cleft, enhancing mood and emotional stability.

Mechanism of Action[edit]

Chemical structure of Oxaflozane

The mechanism of action of Oxaflozane involves modulation of the serotonergic system. It binds to serotonin receptors, particularly the 5-HT1A receptor, acting as a partial agonist. This action helps in normalizing the serotonergic activity in the brain, which is often disrupted in patients with depression and anxiety disorders.

Clinical Use[edit]

Oxaflozane is prescribed for patients diagnosed with major depressive disorder and generalized anxiety disorder. It is considered effective in cases where patients do not respond adequately to other antidepressants. The drug is administered orally, and the dosage is adjusted based on the patient's response and tolerance.

Side Effects[edit]

Common side effects of Oxaflozane include nausea, dizziness, and insomnia. Some patients may experience dry mouth, constipation, or sexual dysfunction. It is important for patients to report any severe or persistent side effects to their healthcare provider.

Contraindications[edit]

Oxaflozane is contraindicated in patients with a known hypersensitivity to the drug or its components. It should be used with caution in patients with a history of bipolar disorder, as it may induce mania.

Related pages[edit]